Category: Family

Antidotative therapy for snakebite

Antidotative therapy for snakebite

This article Antidotattive part of the Antidotative therapy for snakebite Topic Venoms and Snaebite At the Crossroads theraapy Basic, Antodotative and Clinical Immunology View all 17 articles. Biodiversity-derived molecules, namely those extracted from Obesity and mental health plants, are promising sources of toxin inhibitors thwrapy can minimize the deleterious snakebiet Antidotative therapy for snakebite SBEs. snaekbite Silva Meirelles L, Fontes AM, Covas DT, Caplan AI. Although myotoxins such PLA2s are directly responsible for myonecrosis while hemorrhagic toxins such SVMPs indirectly contribute to this damage, it is remarkable how muscle regeneration in the presence of both types of toxins is significantly compromised, while in the presence of only PLA2, muscle recovers from myonecrosis without important abnormalities 8 This protocol rejuvenates mitochondria in MSC with the advantages of i not incorporating Fetal Bovine Serum FBS and avoiding the possibility of animal-to-human contamination and free of Human Platelet Lysate, which increases fibrinogen and prothrombosis.


Treating Snake Bites

Antidotative therapy for snakebite -

Take a photograph of the snake from a safe distance if possible. Identifying the snake can help with treatment of the snakebite. Keep calm. Inform your supervisor. Apply first aid while waiting for EMS staff to get you to the hospital. Lay or sit down with the bite in a neutral position of comfort.

Remove rings and watches before swelling starts. Wash the bite with soap and water. Cover the bite with a clean, dry dressing. Do NOT do any of the following: Do not pick up the snake or try to trap it.

NEVER handle a venomous snake, not even a dead one or its decapitated head. Do not wait for symptoms to appear if bitten, get medical help right away. Do not apply a tourniquet. Do not slash the wound with a knife or cut it in any way. Do not try to suck out the venom.

Do not apply ice or immerse the wound in water. Do not drink alcohol as a painkiller. Do not take pain relievers such as aspirin, ibuprofen, naproxen. Do not apply electric shock or folk therapies. Page last reviewed: June 28, Content source: National Institute for Occupational Safety and Health.

Results show that 52 is considered a potential antmyotoxic agent Chalcone butein 53 , isolated from Butea monosperma Fabaceae , inhibited the activity of daboxin P, a PLA 2 s, with an IC 50 value of µM.

When analyzing the effect of the isoflavone harpalycin 2 54 , isolated from the leaves of Harpalyce brasiliana Fabaceae from Brazil state of Ceará and used in folk medicine as an anti-inflammatory for the treatment of snakebites, promising activities were found.

Compound 54 inhibited the enzymatic activity and edematogenic and myotoxic effects of PLA 2 s from B. pirajai , C. durissus and N. naja venoms. Piratoxin 3 PrTX-III B. Edema in mouse paws induced by exogenous administration of PLA 2 s showed significant inhibition by harpalycin 2 Har2 in the initial stage.

In addition, Har2 also inhibited the myotoxic activity of these PLA 2 s 95 , jararacussu The neuromuscular blockade caused by BthTX-I, the main myotoxic PLA 2 s of this venom, was also attenuated by The derivatives of isoflavonoids, pterocarpans and coumestans, have also been identified as antivenom agents.

Pterocarpan edunol 56 , isolated from the root of Brongniartia podalyrioides Fabaceae from Mexico, reduced the lethality of B. Substance 56 was also isolated from the root of Harpalyce brasiliana Fabaceae from Brazil. It was obtained by synthesis in order to obtain larger amounts of material for the tests and also showed antimyotoxic, antiproteolytic and anti-PLA 2 s properties These properties could be enhanced by the synthesis of a derivative of 56 , the bioisostere 56a , in which the prenyl group was replaced by the benzyl group.

Compound 56a was able to fully inhibit the myotoxic activity of the venom by pre-incubation in vitro with an IC 50 of 9. Other prenylated pterocarps in ring A are described as very active compounds against B. atrox venom, with cabenegrins A-I 57 and A-II 58 being potential lead compounds These substances were isolated from the plant Annona crassiflora Annonaceae , which is a popular medicinal plant from northeastern Brazil that is used for treating snakebite Figure 6 and Table 3.

The coumestan, wedelolactone 59 has been isolated from species such as Eclipta alba and E. prostrate Asteraceae in Brazil state of São Paulo , , In the study by Diogo et al.

jararacussu BthTX-I and II Active at 30 µM, the analogue of wedelolactone 59a , which was synthesized with different patterns of oxygenation in the A and D rings, antagonized the release of creatine kinase CK induced by the venom of B.

jararacussu in skeletal muscle. Compound 59a also inhibited the myotoxic activity of the venom with an IC 50 of 1 µM, which is similar to that of the wedelolactone compound In addition, compound 59a was shown to be less potent for binding to benzodiazepine receptors, indicating that 59a is less susceptible to producing adverse effects in the central nervous system Given the results, it is possible that these products may be useful in the therapy of snakebite and other coagulation disorders Another study proved the inhibitory effect of the compound demethylwedelolactone 60 from E.

alba , in which it neutralized the myotoxic activity induced by isolated PLA 2 s BthTX-I and II from C. jararacussu venom Figure 6 and Table 3. Despite being active, all modified glycosides showed that they possessed lower potential when compared with other natural product classes. Figure 7 Chemical structures of snakebite treatment compounds Table 4 Modified glycosides and polyketides with antivenom properties.

Two new phenolic glycosides, scoloquinenoside C 65 and scoloposide C 66 , were isolated from the stem of S. chinensis Salicaceae in China. In addition, phenolic glycosides have shown inhibitory activity against PDE-I from snake venom Another study also showed inhibitory activity against PDE-I from snake venom, in which two new phenolic glycosides called benzoylsalreposide 67 IC 50 of µM and salireposide 68 IC 50 of µM were used.

These were isolated from Symplocos racemosa Symplocaceae from Pakistan , Figure 7 and Table 4. The natural naphthoquinone, lapachol 69 , was isolated from the species Tabebuia impetiginosa Bignoniaceae from Brazil state of Rio de Janeiro , and has been used as a starting point for obtaining new bioactive quinones In this same work, an analogue of this natural compound 69a showed the ability to antagonize the proteolytic activity µM and collagenase activity µM of B.

atrox and, in relation to the venom of B. The authors attributed the protective effect of the analogue of 69a in the skin to the inhibition of proteolytic activities and collagenase, i. Another naphthoquinone, isohemigossypolone 70 , isolated from the roots of Pachira aquatica Malvaceae from Brazil state of Bahia , was able to significantly inhibit the in vitro coagulant activity of B.

pauloensis venom. In in vivo experiments, the compound was able to significantly inhibit myotoxic activity caused by B.

Selvanayagam et al. isolated a quinonoid xanthene from the root bark of the species Ehretia buxifolia Boraginaceae from India Tamilnadu , which is used as an antidote for E.

carinatus envenomation The compound ehretianone 71 was isolated from the methanolic extract of the bark of the plant species and was tested for antivenom activity against envenomations by E.

carinatus in mice. In prophylactic treatment, the dosage of 3. In the curative study, the same dosage of the compound gave significant protection up to 5 min after the injection of venom.

Melanin 72 extracted from black tea is a non-hydrolyzed complex of tea polyphenols and has been tested for its effect on venoms of the snakes A. contortrix , A. halys and C. The sesquiterpene ar-turmerone 73 , isolated from the roots of Curcuma longa Zingiberaceae from Brazil state of Minas Gerais , was able to neutralize the hemorrhagic activity present in the venom of B.

jararaca and reduced the lethal effect of the venom of C. Another study performed with this compound and the venom of B. alternatus found that, in the first treatment, the hemorrhagic activity presented a reduction of the hemorrhagic halo of 3. In addition, the necrosis that had occurred was reversed in all animals in a period of 96 h Figure 8 and Table 5.

Figure 8 Chemical structures of snakebite treatment compounds In relation to the diterpenes, E ethyliden-labdene,dial labdane dialdehyde 74 , isolated from the species C. zedoaroides Zingiberaceae from Thailand, showed an increase in the antagonistic antivenomous effects of O.

hannah occurred Lattmann et al. In this way, this compound acted as a mold for molecular recognition that was able to guide the dialdehyde irreversibly to the peptide target of the venom, and the complex that was formed was unable to block the nAChRs Figure 8 and Table 5.

In a subsequent study, Salama et al. isolated the diterpenes 74 , labdane lactone 75 and labdane trialdehyde 76 from species of the genus Curcuma Zingiberaceae , also in Thailand antinaia and C. hannah venom. Substance 76 , obtained from C. The compound neo -clerodane 77 , isolated from the aerial parts of the plant Baccharis trimera Asteraceae from Brazil state of São Paulo , significantly inhibited the hemorrhagic activity of venoms from Bothrops spp.

and of the isolated SVMP Bjussu-MP-I from B. jararacussu venom jararacussu Figure 8 and Table 5. Within the subclass of triterpenes, lupeol acetate 78 is isolated from the roots of H.

indicus Asclepiadaceae and is found in several other plants that are studied regarding antivenom activity. This compound significantly neutralized lethality, hemorrhagic, defibrinogenation, edematogenic and PLA 2 s activities induced by D.

russelii venom. It also neutralized lethality, cardiotoxicity, neurotoxicity and respiratory alterations caused by N. kaouthia venom. Compound 77 induced greater protection against the venoms of D. russelii and N. kaouthia when administered together with the antivenom compared to the action of treatment only with antivenom naja in vitro.

In silico assays showed that both compounds were well inserted in the active site of PLA 2 s Oleanolic acid 81 is the main metabolite found in several medicinal plants used in the treatment of inflammatory disorders.

russeli and N. naja with an IC 50 of 3. In addition, 81 inhibited indirect hemolytic activity and PLA 2 s-induced mouse paw edema in vivo. Further studies were conducted with the PLA 2 s of D. russelii venom and revealed that inhibition by 81 is not dependent on the substrate and calcium, and causes an inhibition that is irreversible.

Results presented by Dharmappa et al. This compound showed inhibition of proteolytic activity induced by the Batx-I SVMP from B. atrox venom, with an IC 50 of In this same study, 81 displayed reductions in the formation of edema induced by metalloprotease at a dose-dependent concentration.

In addition, two other pentacyclic triterpenoids, betulinic acid 82 and ursolic acid 83 of synthetic origin, also inhibited the proteolytic activity of Batx-I with IC 50 values of and µM, respectively. Additionally, inhibition of hemorrhagic activity was observed with an IC 50 of and 1.

Zalewski et al. durissus venom Compound 83 was also effective in inhibiting the PLA 2 s enzyme of D. It was also able to antagonize the induction of edema caused by D. russelii venom at a concentration of 12 µM Figure 8 and Table 5. The compounds quinovic acid 84 and quinovin glycoside C 85 , isolated from the stem of the plant Mitragyna stipulosa Rubiaceae , from Cameroon, showed significant inhibitory activity against PDE-I of snake venom with IC 50 values of 0.

In addition, at some concentrations, 86 inhibited some enzymatic activities, such as PLA 2 s, collagenase, proteolytic and hyaluronidase, of B.

jararaca venoms at a dose-dependent concentration Isolated from the stem of the species of E. ovalifolium and E. The study by Ferraz et al. showed the efficacy of triterpenoids isolated from D. alata Fabaceae from Brazil state of Tocantins , which were tested 0. durissus envenomations of the neuromuscular junction.

jararaca Within the subclass of the steroids, ikshusterol 3- O -glucoside 93 , isolated from C. In addition, in vitro assays showed a good ability to inhibit the PLA 2 s In in vitro studies, the mixtures of the compounds β -sitosterol 94 and stigmasterol 95 , extracted from the roots µg of Pluchea indica Asteraceae in India, showed protection against lethality, hemorrhagic activity, defibrinogenation, cardiotoxicity, neurotoxicity, respiratory changes, and inhibition of the activity of PLA 2 s and the edema induced by the venom of D.

kaouthia The synthetically obtained corticosteroid corticosterone 96 showed effective inhibitory activity of the enzyme PLA 2 s present in the venom of D. russelii with an IC 50 of Bakuchiol 97 , a synthetic meroterpenoid, inhibited the activity of the main PLA 2 s enzyme, daboxin P, with an IC 50 of µM Figure 8 and Table 5.

Some saponins have also been reported as snake venom inhibitors. The triterpene saponin bredemeyeroside B 98 , isolated from the roots of Bredemeyera floribunda Polygalaceae from Brazil state of Ceará , showed inhibitory action against the lethality of the venom of B.

From this same species, bredemeyroside D 99 was isolated, which was also able to show inhibitory action of the lethality of the venom of B. Glycyrrhizin , extracted from the roots of the plant Glycyrrhiza glabra Fabaceae from Brazil state of São Paulo , had an in vitro inhibitory effect on human fibrogen coagulation induced by B.

jararaca venom IC 50 1. Figure 9 Chemical structures of snakebite treatment compounds Table 6 Saponins and other compounds with antivenom properties. The compounds macrolobin A and macrolobin B were isolated from the bark of Pentaclethra macroloba Fabaceae from Brazil state of Amapá , and significantly inhibited the hemorrhagic and the fibrogenolytic activities of Bothrops venoms and the SVMP Bjussu-MP-I from B.

jararacussu venom, and were shown to be dose dependent Regarding coagulation activity, was able to completely inhibit B.

jararacussu venom and the thrombin-like enzyme Bjussu-SP-I afterincubation periods of 1 h and 30 min, respectively The glycosidic derivatives of quinovic acid, first isolated from the bark of Bridelia ndellensis Euphorbiaceae collected in Cameroon Ngaoundre , showed inhibitory activities against the enzyme PDE-I phosphodiesterase-I.

Fozing et al. The compounds mesozygin B and artonine I showed the most potent activity, with an IC 50 of 8. Other compounds have also shown effective inhibitory activity of enzymes present in snake venom. Stilbene resveratrol and an aliphatic derivative polyamine gramine {3-[3- dimethylaminomethyl -1 H -indolYL] propanol} were tested for the inhibition capacity of the PLA 2 s enzyme of D.

russelii venom and presented an IC 50 of In this same work, studies were carried out to verify the interactions of PLA 2 s with the compounds, in addition to determining the structures of PLA 2 s complexes with these compounds.

In in vitro experiments, the amino acid mimosine [ β 3-hydroxyoxopyridyl alpha-amino-propionic acid] inhibited HAases DRHyal-II in a dose-dependent manner, and its activity with complete inhibition at 24 µM and an IC 50 value of 12 µM.

In addition, also neutralized the same activity of D. russelii venom in a dose-dependent manner. The hyaluronidase activity of the venom was eliminated at µM with an IC 50 value of µM. In in vivo experiments, inhibited DRHyal-II-potentiated myotoxicity of the myotoxin VRV-PL-VIII myotoxic PLA 2 s In the study by Devi et al.

naja carinatus Additionally, compound inhibited the PLA 2 s activity of daboxin P with an IC 50 value of Another study confirmed the phytomedicinal value of diisobutyl pthalate, 2-methylpropyl phthalate , present in the root of Emblica officinalis Phyllanthaceae from India, which antagonized the myotoxicity induced by the venom of D.

russelii , shown by the decreased levels of the myotoxicity marker enzymes CPK and LDH The inhibitory effect of the bioactive polyphenol curcumin on the activity of the enzyme HAases purified from the venom of N. In addition, plant extracts used in folk medicine were evaluated for inhibition of the enzymatic activity of myotoxin I and a PLA 2 s from B.

asper venom. The compound 4-nerolidylcatechol , isolated from Piper umbellatum and P. peltatum Piperaceae from Costa Rica Upala and Guapiles , inhibited the PLA 2 s activity of myotoxin I of B.

asper and B. atrox at a time-and concentration-dependent dose IC 50 of 1 mM. This compound was also able to inhibit PLA 2 ss activity of group I of pseudexin and Micrurus mipartitus venom, and of group II as Bothrops toxins Additionally, when pre-treated with 0.

For Núñez et al. jararacussu Figure 9 and Table 6. The fatty alcohol 1-hydroxytetratriacontanone , isolated from the leaves of Leucas aspera Lamiaceae , showed strong activity against the venom of N.

naja in in vivo tests, with a mean effective dose ED 50 of An acid glycoprotein, isolated from the species Withania somnifera Solanaceae from India and named WSG, has been identified as a possible inhibitor of snake venoms. In experiments with N.

naja venom, the compound was able to inhibit PLA 2 s in vitro ratio , and inhibited edema induction concentration , and also neutralized the phospholipase-induced myotoxicity of Indian snake venom N.

naja at the molar ratio of PLA 2 s:WSG In other studies, the same compound also inhibited the catalytic activity of different PLA 2 s isoforms of N. naja venom, increased the survival time of mice and inhibited the activity of the HAases enzyme of the venoms of N.

naja and D. Turmerin, a protein of the Indian species C. longa Zingiberaceae common name: turmeric was effective in the inhibition of cytotoxicity in a dose-dependent manner, and also effectively inhibited the edema induced by phospholipase, which is a toxic venom of N.

naja PLA 2 s , in a molar ratio of naja, N. kauthia, N. melanoleuca , A. halys , B. orientis and Oxyuranus scutellatus with an IC 50 of 0. Historically, natural products have played a key role in drug discovery and are invaluable resources that can contribute, especially as adjuvant inhibitors, to neutralizing the action of snake venom toxins.

However, difficulties are still encountered with natural products in the process of developing new drugs, despite numerous examples of successful applications throughout history. These difficulties, which are centered on low yields, difficulties in purification, as well as high rates of rediscovery, are a recurring problem in research with natural products.

Recently, new tools for the study of natural products have been introduced, especially molecular biology techniques, which allow access to silenced or orphaned biosynthetic gene clusters; however, such applications have been mostly applied in microbial chemistry.

Solutions for this type of study with plants have also been implemented, particularly based on transcriptomics In addition, more sensitive analytical methods have been developed, which permit more comprehensive metabolomic analysis, which can be combined with new data analysis tools such as GNPS Global Natural Products Social Molecular Networking Although the vast majority of inhibitors of snake toxins originate in plants, given the lack of information on the natural products of these organisms against snake venom, microbial chemistry still represents a potential area to be explored.

Another untapped potential target is marine organisms also including microorganisms , which have already proven to be valuable sources of new lead compounds It is worth noting that natural products are still in second place, when compared to synthetic compounds, especially those that are easily obtained and have proven human safety via clinical trials.

In particular, the repositioning of drugs emerges as a valuable strategy, especially nowadays due to the SARS-COV pandemic, which has forced us to search for new treatments.

In the field of SBEs, much of the efforts focusing on the auxillary treatment relies on drugs of synthetic origin or those that have lower production costs. With this, the time interval between the identification of a potentially useful molecule and the approval for human use is lower due to the availability of safety data.

Small molecules already provide an p-talternative application via the reuse of drugs in SBEs. Promising drug candidates such as batimastat, marimastat and varespladib have already advanced to phase II and phase III in preclinical trials 10 , , Combined with chemical methods, there is an increasing demand for methodologies that are capable of adequately simulating more complex biological conditions in order to better evaluate the effects of extracts and isolated natural products.

Efforts such as the development of models with zebrafish, and other organisms, have met both the demands of researchers and the demands of more ethical laboratory practices. As such, knowledge regarding the chemical composition of the venom of the snake of origin is fundamental, since it allows the rationalization of studies aimed at the isolation of toxins.

With the purified toxins, there is the possibility of their use in assays, as well as the information on crystalline structures, which aids studies on their mechanism of action, and also encourages computational research on structure-activity.

Discovering and developing molecules as new drug candidates is a complex long-term task with many obstacles, and this process involves a high cost. However, history has shown that research on natural products still has much to contribute to the advancement of knowledge for solving public health problems, especially those that are often neglected such as SBEs.

Plants have served as important sources of medicine for snakebite complications, and this is attributed to the presence of several chemical compounds that are capable of inhibiting venom toxins. In this sense, this review sought to provide a more comprehensive knowledge of natural inhibitors isolated from plants for use against venoms and toxins and, in some way, contribute to the knowledge of potential options for auxillary treatment of SBEs.

According to the papers analyzed, it was possible to identify natural inhibitors from around the world that are commonly used as snake venom inhibitors. These findings deserve further attention and further studies in pre-clinical trials involving animals to direct future clinical applications in humans.

AA, AS, MS, WM, and HK conceived the main idea of this work. AA, AS, EL, WP, JM, and FS conducted the bibliography search. AA, AS, and WP designed the figures of this review article. MP, AM-d-S, WM, MS, and HK corrected the manuscript and provided important contributions during the development of this work.

All authors listed have made a substantial intellectual contribution to the work and approved it for publication.

The authors would also like to thank Conselho Nacional de Desenvolvimento Científico e Tecnológico CNPq for the payment of scholarships to MBP No. MP Snakebite Roraima project coordinator acknowledges funding support from the Hamish Ogston Foundation - Global Snakebite Initiative.

This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior — Brasil CAPES — Finance Code The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. We thank Mr. Cícero Antônio Paula Barros, chief of the Division of Indigenous Health Care, of the Special Secretariat Indigenous Health District - East of Roraima.

Snakebite Envenoming Key Facts Google Scholar. Williams DJ, Faiz MA, Abela-Rider B, Ainsworth S, Bulfone TC, Nickerson AD, et al.

Strategy for a Globally Coordinated Response to a Priority Neglected Tropical Disease: Snakebite Envenoming. PloS Negl Trop Dis e doi: PubMed Abstract CrossRef Full Text Google Scholar. Yue S, Bonebrake TC, Gibson L.

Human-Snake Conflict Patterns in a Dense Urban-Forest Mosaic Landscape. Herpetol Conserv Biol — Chippaux JP. Snakebite Envenomation Turns Again Into a Neglected Tropical Disease!

J Venomous Anim Toxins Including Trop Dis CrossRef Full Text Google Scholar. Bolon I, Durso AM, Botero MS, Ray N, Alcoba G, Chappouis F, et al.

Identifying the Snake: First Scoping Review on Practices of Communities and Healthcare Providers Confronted With Snakebite Across the World.

PloS One e Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, William DJ, Warrell DA. Snakebite Envenoming. Nat Rev Dis Primers — Estimate of the Burden of Snakebites in Sub-Saharan Africa: A Meta-Analytic Approach.

Toxicon — Habib AG, Kuznik A, Hamza M, Abdullahi MI, Chedi BA, Chippaux JP, et al. Snakebite Is Under Appreciated: Appraisal of Burden From WestAfrica. PloS Negl Trop Dis 9:e Resiere D, Monteiro WM, Houcke S, Pujo JM, Mathien C, Mayence C, et al.

Bothrops Snakebite Envenomings in the Amazon Region. Curr Trop Med Rep — Gutiérrez JM, Albulescu LO, Clare RH, Casewell NR, Abd El-Aziz TM, Escalante T, et al.

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming. Toxins Vonk FJ, Admiraal JF, Jackson K, Reshef R, Bakker MAG, Vanderschoot K, et al.

Evolutionary Origin and Development of Snake Fangs. Nature —3. Alirol E, Sharma SK, Bawaskar HS, Kuch U, Chappuis F. Snake Bite in South Asia: A Review.

PloS Negl Trop Dis —9. Bhargava S, Kaur R, Singh R. Epidemiological Profile of Snake-Bite Cases From Haryana: A Five Year — Retrospective Study. J Forensic Legal Med — Patra A, Kalita B, Mukherjee AK. Assessment of Quality, Safety, and Pre- Clinical Toxicity of an Equine Polyvalent Anti-Snake Venom Pan Africa : Determination of Immunological Cross-Reactivity of Antivenom Against Venom Samples of Elapidae and Viperidae Snakes of Africa.

Toxicon —7. Malaque CMS, Gutiérrez JM. Snakebite Envenomation in Central and South America. Crit Care Toxicol 1— Greene S. Coral Snake Envenomations in Central and South America. CurrTrop Med Rep —6. Costa MKB, Fonseca CS, Navoni JA, Freire EMX. Snakebite Accidents in Rio Grande do Norte State, Brazil: Epidemiology, Health Management and Influence of the Environmental Scenario.

Trop Med Int Health — Calvete JJ, Lomonte B. Present and Future of Snake Venom Proteomics Profiling. Handb Venoms Toxins Reptiles — Liu S, Yang F, Zhang Q, Sun MZ, Gao Y, Shao S. Anatomical Record: Adv Integr Anat Evol Biol — Sanhajariya S, Iabister GK, Duffull SB.

The Influence of the Different Disposition Characteristics of Snake Toxins on the Pharmacokinetics of Snake Venom.

Tasoulis T, Isbister GK. A Review and Database of Snake Venom Proteomes. Toxins — Brahma RK, Mcleary RJR, Kini RM, Doley R. Venom Gland Transcriptomics for Identifying, Cataloging, and Characterizing Venom Proteins in Snakes. Luna MS, Valente RH, Perales J, Vieira ML, Yamanouye N.

Activation of Bothrops jararaca Snake Venom Gland and Venom Production: A Proteomic Approach. J Proteomics — Ferraz CR, Arrahman A, Xie C, Casewell NR, Lewis R, Kool J, et al. Multifuncional Toxins in Snake Venoms and Therapeutic Implications From Pain to Hemorrhage and Necrosis.

Front Ecol Evol Ojeda PG, Ramı́rez D, Morales JA, Caballero J, Kaas Q, González W. Computational Studies of Snake Venom Toxins. Laustsen AH, Lohse B, Lomonte B, Engmark M, Gutierrez JM. Selecting Key Toxins for Focused Development of Elapid Snake Antivenoms and Inhibitors Guided by a Toxicity Score.

Toxicon —5. Casewell NR, Wagstaff SC, Wuster W, Cook DAN, Bolton FMS, King SI, et al. Medically Important Differences in Snake Venom Composition are Dictated by Distinct Postgenomic Mechanisms.

Proc Natl Acad Sci — Oliveira ICF, Paula MO, Lastra HCB, Alves BB, Moreno DAN, Yoshida EH, et al. Activity of Silver Nanoparticles on Prokaryotic Cells and Bothrops jararacussu Snake Venom.

Drug Chem Toxicol —4. Oliveira SS, Alves EC, Santos AS, Pereira JP, Sarraff LKS, Nascimento EF, et al. Factors Associated With Systemic Bleeding in Bothrops Envenomation In a Tertiary Hospital in the Brazilian Amazon.

Monteiro WM, Bernal JCC, Bisneto PF, Sachett J, Silva IM, Lacerda M, et al. Bothrops atrox , the Most Important Snake Involved in Human Envenomings in the Amazon: How Venomics Contributes to the Knowledge of Snake Biology and Clinical Toxinology. Toxicon:X Moura-da-Silva AM, Bernal JCC, Gimenes SNC, Sousa LAF, Junior JAP, Peixoto OS, et al.

The Relationship Between Clinics and the Venom of the Causative Amazon Pit Viper Bothrops atrox. Harris JB, Scott-Davey T. Secreted Phospholipases A 2 of Snake Venoms: Effects on the Peripheral Neuromuscular System With Comments on the Role of Phospholipases A 2 in Disorders of the CNS and Their Uses in Industry.

Nicola MRD, Pontara A, Kass GEN, Kramer NI, Avella I, Pampena R, et al. Vipers of Major Clinical Relevance in Europe: Taxonomy, Venom Composition, Toxicology and Clinical Management of Human Bites. Toxicology Gutiérrez JM, Lomonte B.

Phospholipases A 2 : Unveiling the Secrets of a Functionally Versatile Group of Snake Venom Toxins. Kanashiro MM, Escocard RCM, Petretski JH, Prates MV, Alves EW, Machado OLT, et al. Biochemical and Biological Properties of Phospholipases A 2 From Bothrops atrox Snake Venom. Biochem Pharmacol — Fox JW, Serrano SMT.

Insights Into and Speculations About Snake Venom Metalloproteinase SVMP Synthesis, Folding and Disulfide Bond Formation and Their Contribution to Venom Complexity. FEBS J — Piperi C, Papavassiliou AG. Molecular Mechanisms Regulating Matrix Metalloproteinases.

Curr Topics Med Chem — Moura-da-Silva AM, Butera D, Tanjoni I. Importance of Snake Venom Metalloproteinases in Cell Biology: Effects on Platelets, Inflammatory and Endothelial Cells. Curr Pharm Design — Takeda S, Takeya H, Iwanaga S.

Biochim Biophys Acta BBA -Proteins Proteomics — Gutiérrez JM, Escalante T, Rucavado A, Herrera C. Hemorrhage Caused by Snake Venom Metalloproteinases: A Journey of Discovery and Understanding. Bickler PE. Amplification of Snake Venom Toxicity by Endogenous Signaling Pathways.

Slagboom J, Kool J, Harrison RA, Casewell NR. Haemotoxic Snake Venoms: Their Functional Activity, Impact on Snakebite Victims and Pharmaceutical Promise.

Br J Haematol — Larréché S, Chippaux JP, Chevillard L, Mathé S, Resiere D, Siguret V, et al. Bleeding and Thrombosis: Insights Into Pathophysiology of Bothrops Venom-Related Hemostasis Disorders.

Int J Mol Sci Teixeira CFP, Fernandes CM, Zuliani JP, Zamuner SF. Inflammatory Effects of Snake Venom Metalloproteinases. Memórias do Inst Oswaldo Cruz —4. Almeida MT, Sousa LAF, Colombini M, Gimenes SN, Kitano ES, Mouro ELF, et al.

Inflammatory Reaction Induced by Two Metalloproteinases Isolate From Bothrops atrox Venom and by Fragments Generated FromThe Hydrolysis of Basement Membrane Components. Kang TS, Georgieva D, Genov N, Murakami MT, Sinha M, Kumar RP, et al.

Enzymatic Toxins From Snake Venom: Structural Characterization andMechanism of Catalysis. Serrano SMT. The Long Road of Research on Snake Venom Serine Proteinases. Page MJ, Di Cera E. Serine Peptidases: Classification, Structure and Function. Cell Mol Life Sci — Sajevic T, Leonardi A, Krizaj I.

Haemostatically Active Proteins in Snake Venoms. Dufton MJ, Hider RC. Structure and Pharmacology of Elapid Cytotoxins. Pharmacol Ther — Kini RM, Doley R. Structure, Function and Evolution of Three-Finger Toxins: Mini Proteins With Multiple Targets.

Lauridsen LP, Laustsen AH, Lomonte B, Gutiérrez JM. Toxicovenomics and Antivenom Profiling of the Eastern Green Mamba Snake Dendroaspis angusticeps. Sanz L, Pla D, Pérez A, Rodrı́guez Y, Zavaleta A, Salas M, et al.

Kessler P, Marchot P, Silva M, Servent D. The Three-Finger Toxin Fold: A Multifunctional Structural Scaffold Able to Modulate Cholinergic Functions. J Neurochem — Kini RM, KOH CY. Snake Venom Three-Finger Toxins And Their Potential in Drug Development Targeting Cardiovascular Diseases.

Biochem Pharmacol , Boldrini-França J, Cologna CT, Pucca MB, Bordon KCF, Amorim FG, Anjolette FAP, et al. Minor Snake Venom Proteins: Structure, Function and Potential Applications. Biochim Biophys Acta BBA -General Subj — Costa TR, Burin SM, Menaldo DL, Castro FA, Sampaio SV. Snake Venom LAmino Acid Oxidases: An Overview on Their Antitumor Effects.

J Venom Anim Toxins incl Trop Dis —7. Izidoro LFM, Sobrinho JC, Mendes MM, Costa TR, Grabner NA, Rodrigues, et al. Snake Venom L-Amino Acid Oxidases: Trends in PharmacologyAnd Biochemistry.

Bio Med Res Int — Pukrittayakamee S, Warrelll DA, Desakorn V, Michael AJM, White NJ, Bunnag D. The Hyaluronidase Activities of Some Southeast Asian SnakeVenoms.

Wahby AF, Mahdy ESME, Mezayen HAE, Salama WH, Aty AMA, Fahmy AS. Egyptian Horned Viper Cerastes cerastes Venom Hyaluronidase Purification, Partial Characterization and Evidence for Its Action as aSpreading Factor.

Toxicon —9. Dhananjaya BL, Gowda TV, Souza CJMD. Evidence for Existence of Venom 5' Nucleotidase in Multiple Forms Through Inhibition of Concanavalin A.

Cell Biochem Funct —2. Santoro ML, Vaquero TS, Leme AFP, Serrano SMT. Xia C, Dong YX, Min D, Hui L, Qiyi H, Ping LJ. Purification and Characterization of 5'-Nucleotidase From Trimeresurus albolabris Venom.

Zool Res — Hart ML, Kohler D, Eckle T, Kloor D, Stahl GL, Eltzschig HK. Arterioscler Thromb Vasc Biol — Ouyang C, Huang TF. Silva JRNJ, AIRD SD. Prey Specificity, Comparative Lethality and Compositional Differences of Coral Snake Venoms. Comp BiochemPhysiol Part C: Toxicol Pharmacol — Alangode A, Rajan K, Nair BG.

Snake Antivenom: Challenges and Alternate Approaches. Gómez-Betancur I, Gogineni V, Ospina AS, Leon F. Perspective on the Therapeutics of Anti-Snake Venom.

World Health Organization. Expert Committee on Biological Standardization; World Health Organization. In: WHO Expert Committee on Biological Standardization: Sixty-Sixth Report.

Geneva, Switzerland: World Health Organization Gutiérrez JM, Leon G, Lomonte B, Angulo Y. Antivenoms for Snakebite Envenomings.

Inflammation Allergy-Drug Targets — Gimenes SNC, Sachett JAG, Colombini M, Sousa LAF, Ibiapina HNS, Costa AG, et al. Observation of Bothrops atrox Snake Envenoming Blister Formation From Five Patients: Pathophysiological Insights.

Feitosa EL, Sampaio VS, Salinas JL, Queiroz AM, Silva IM, Gomes AA, et al. Older Age and Time to Medical Assistance are Associated With Severity and Mortality of Snakebites in the Brazilian Amazon: A Case-Control Study. Laustsen AH, Gutiérrez JM, Knudsen C, Johnsen KH, Méndez EB, Cerni FA, et al.

Pros and Cons of Different Therapeutic Antibody Formats for Recombinant Antivenom Development. Magalhães SFV, Peixoto HM, Sachett JAG, Oliveira SS, Alves EC, Ibiapina, et al. Snakebite Envenomation in the Brazilian Amazon: A Cost-Of-Illness Study. Trans R Soc Trop Med Hyg —9.

Samy RP, Thwin MM, Gopalakrishnakone P, Ignacimuthu S. Ethnobotanical Survey of Folk Plants for the Treatment of Snakebites in Southern Part of Tamilnadu, India.

J Ethnopharmacol — Fry BG. Snakebite: When the Human Touch Becomes a Bad Touch. Lomonte B, Léon G, Angulo Y, Alexandra R, Núñez V.

Neutralization of Bothrops asper Venom by Antibodies, Natural Products and Synthetic Drugs: Contributions to Understanding Snakebite Envenomings and Their Treatment.

Williams DJ, Habib AG, Warrell DA. Clinical Studies of the Effectiveness and Safety of Antivenoms. Knudsen C, Ledsgaard L, Dehli RI, Ahmadi S, Sorense CV, Laustsen AH. Engineering and Design Considerations for Next-Generation SnakebiteAntivenoms.

Sorokina M, Steinbeck C. Review on Natural Products Databases: Where to Find Data in J Cheminform — Nargotra A, Sharma S, Alam MI, Ahmed Z, Bhagat A, Taneja SC, et al. In Silico Identification of Viper Phospholipase A 2 Inhibitors: Validation by In Vitro , In Vivo Studies.

J Mol Modeling — Félix-Silva J, Júnior AAS, Zucolotto SM, Pedrosa MFF. Medicinal Plants for the Treatment of Local Tissue Damage Induced by Snake Venoms: An Overview From Traditional Use to Pharmacological Evidence.

Evidence-Based Complementary Altern Med Newman DJ, Cragg GM. J Natural Products — Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural Products in Drug Discovery: Advances and Opportunities. Nat Rev Drug Discov — Janardhan B, Shrijanth VM, Mirajkar KK, More SS.

In Vitro Anti-Snake Venom Properties of Carisssa spinarum Linn Leaf Extracts. J Herbs Spices Medicinal Plants — Selvanayagam ZE, Gnanavendhan SG, Balakrishna K, Rao RB, Sivaraman J, Subramanian K, et al.

Ehretianone, A Novel Quinonoid Xanthene From Ehretia buxifolia With Antisnake Venom Activity. J Nat Prod —7. Dey A, De JN. Traditional Use of Plants Against Snakebite in Indian Subcontinent: A Review of the Recent Literature. Afr J Trad Complem Altern Medi — Otero R, Núñez V, Jiménez SL, Fonnegra R, Osorio RG, García ME, et al.

Snakebites and Ethnobotany in the Northwest Region of Colombia: Part II: Neutralization of Lethal and Enzymatic Effects of Bothrops atrox Venom. J Ethnopharmacology — Owuor BO, Kisangau DP.

Kenyan Medicinal Plants Used as Antivenin: A Comparison of Plant Usage. J Ethnobiol Ethnomedicine —8. Omara T, Nakiguli CK, Naiyl RW, Opondo FA, Otieno SB, Ndiege ML, et al. Medicinal Plants Used as Snake Venom Antidotes in East African Community: Review and Assessment of Scientific Evidences.

J Medicinal Chem Sci — Okot DF, Anywar G, Namukobe J, Byamukama R. Medicinal Plants Species Used by Herbalists in the Treatment of Snakebite Envenomation in Uganda. Trop Med Health — Owuor BO, Mulemi BA, Kokwaro JO.

Indigenous Snake Bite Remedies of the Luo of Western Kenya. J Ethnobiol — Vale HF, Mendes MM, Fernandes RS, Costa TR, Melim LISH, Sousa MA, et al. Protective Effect of Schizolobium parahyba Flavonoids Against Snake Venoms and Isolated Toxins. Curr Topics Medicinal Chem — Salazar M, Chérigo L, Acosta H, Otero R, Luis SM.

Evaluation of Anti- Bothrops asper Venom Activity of Ethanolic Extract of Brownea rosademonte Leaves. Acta Pharm — Ximenes RM, Alves RS, Pereira TP, Araújo RM, Silveira ER, Rabello MM, et al.

Harpalycin 2 Inhibits the Enzymatic and Platelet Aggregation Activities of PrTX-III, a D49 Phospholipase A 2 From Bothrops pirajai Venom.

BMC Complementary Altern Med — Ximenes RM, Rabello MM, Araújo RM, Silveira ER, Fagundes FH, Diz-Filho EB, et al. Inhibition of Neurotoxic Secretory Phospholipases A 2 Enzymatic, Edematogenic, and Myotoxic Activities by Harpalycin 2, an Isoflavone Isolated From Harpalyce brasiliana Benth.

Evidence-Based Complementary Altern Med —9. Ferraz MC, Parrilha LAC, Moraes MSD, Filho JA, Cogo JC, Santos MG, et al. The Effect of Lupane Triterpenoids Dipteryx alata Vogel in the In Vitro Neuromuscular Blockade and Myotoxicity of Two Snake Venoms.

Curr Organic Chem — Ferraz MC, Yoshida EH, Tavares RV, Cogo JC, Cintra AC, Dal Belo CA, et al. An Isoflavone From Dipteryx alata Vogel is Active Against the In Vitro Neuromuscular Paralysis of Bothrops jararacussu Snake Venom and Bothrops toxin I, and Prevents Venom-Induced Myonecrosis.

Molecules — Silva AJ, Coelho AL, Simas AB, Moraes RA, Pinheiro DA, Fernandes FF, et al. Synthesis and Pharmacological Evaluation of Prenylated and Benzylated Pterocarpans Against Snake Venom.

Bioorganic Medicinal Chem Lett —5. Silva JO, Fernandes RS, Ticli FK, Oliveira CZ, Mazzi MV, Franco JJ, et al. Triterpenoid Saponins, New Metalloprotease Snake Venom Inhibitors Isolated From Pentaclethra macroloba.

Assafim M, Ferreira MS, Frattani FS, Guimarães JA, Monteiro RQ, Zingali RB. Counteracting Effect of Glycyrrhizin on the Hemostatic Abnormalities Induced by Bothrops jararaca Snake Venom.

Br J Pharmacol — Reyes-Chilpa R, Gómez-Garibay F, Quijano L, Magos-Guerrero GA, Ríos T. Preliminary Results on the Protective Effect of - -Edunol, a Pterocarpan From Brongniartia podalyrioides Leguminosae , Against Bothrops atrox Venom in Mice.

Pereira NA, Pereira BM, Nascimento MC, Parente JP, Mors WB. Pharmacological Screening of Plants Recommended by Folk Medicine as Snake Venom Antidotes; IV. Protection Against Jararaca Venom by Isolated Constituents1.

Planta Med — Gómez-Betancur I, Pereañez JA, Patiño AC, Benjumea D. Inhibitory Effect of Pinostrobin From Renealmia alpinia , on the Enzymatic and Biological Activities of a PLA 2. Int J Biol Macromolecules — Salama R, Sattayasai J, Gande AK, Sattayasai N, Davis M, Lattmann E.

Identification and Evaluation of Agents Isolated From Traditionally Used Herbs Against Ophiophagus hannah Venom. Drug Discov Ther — Lattmann E, Sattayasai J, Sattayasai N, Staaf A, Phimmasone S, Schwalbe CH, et al. In-Vitro and In-Vivo Antivenin Activity of 2-[2- 5,5,8a-TrimethylMethylene-Decahydro-NaphthalenYl -Ethylidene]-Succinaldehyde Against Ophiophagus hannah Venom.

Thank you for visiting nature. You are using a browser version Antidotative therapy for snakebite limited support for CSS. Antidotatlve obtain the Antidotative therapy for snakebite experience, we Antidootative you use a Evidence-based weight strategies up to date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Nanoparticles made from titanium dioxide can neutralise the toxic effects of snake venom, a study reveals 1. These nanaoparticles could emerge as a potential antidote to snakebite.

Tropical Antidotaitve and Health volume 48Theraly number: 6 Cite this article. Theraapy details. Snakebite envenomation is Antidotatibe serious public health concern Type diabetes advocacy rural areas of Uganda.

Migraine relief remedies are poorly documented in Uganda because most Antidotativw in rural settings Digestive enzyme deficiency traditional therapists end Weight management for teenagers being the first-line defense for treatment.

Ethnobotanical surveys in Antidotatice have reported that some plants are used to antagonize the snakebitte of various snake Antidotatjve. This review therappy sought theraly identify antivenin plants in Uganda and some pharmacological evidence supporting their use.

Antidotativs literature survey done in multidisciplinary ssnakebite revealed that Antixotative plant species belonging Antidotative therapy for snakebite 65 genera and 42 snakenite are used snakebife the treatment of snakebites Antiddotative Uganda.

Therapg most frequently gor species were Allium cepa Anfidotative, Carica papayaSecuridaca AnfidotativeHarrisonia abyssinicaand Nicotiana Antidootative. Species with global reports of tested snkebite activity snakebbite Allium cepa, Allium Catfish Species Identification, Basella albaCapparis tomentosa, Carica papaya, Cassia occidentalis, Jatropa carcus, Vernonia cinereal, Bidens pilosa, Hoslundia opposita, Maytensus senegalensis, Securinega virosatheerapy Solanum incanum.

There is need to identify and evaluate the antivenom compounds in the claimed plants. Snake envenoming is a global health problem and Antidotative therapy for snakebite justification snkaebite morbimortality snakebiye various snakebitw losses. Antidotaive recent conservative global estimate points that about 5.

Antiotative toof these cases are Antidotatjve in Africa [ 34therqpy ]. Incases of snakebites were reported in Gulu Regional Hospital Uganda though none of Metformin and appetite control victims died [ 6 ].

A retrospective part of this snakbeite showed therapu in surveyed facilities, snakebite cases were recorded within six months snakrbite bites reported in the snakebute seasons from Antidotatuve to Antidotqtive and then October Antidotxtive December [ 8 ].

Thus, tehrapy in Antidotative therapy for snakebite areas theray due to snakebiite of antidotes within the Antidogative h snakebtie [ 6 snakebitr, 910 ] and antisera Athlete bone fracture prevention problems Antidotativd 1112 ].

Snakes are AAntidotative carnivorous Anitdotative of class Reptilia, Anitdotative Squamata, sub-order Serpentes and families : ColubridaeBoidaeElapidae, Matcha green tea ice creamSnakbeite that Atnidotative kill their prey by constriction rather than envenomation [ 1314 ].

Antjdotative bites Antidottative due to Antidoattive stepping on therspy snakes by unprotected or barefooted victims [ 6Antiditative ], snake ecology [ 16 snakebote while Healthy aging lifestyle are initiated by malevolent and snakebitd victims [ 17 therap, 18sbakebite ].

Fot Africa is home to Antidotative therapy for snakebite species of snakes thearpy of Antidoattive from 45 genera and 7 families Antidottative found in Uganda [ 21 ]. Snake venom is secreted by snake oral glands and snakeite injected subcutaneously or intravenously through the fangs into the Improves mental stamina and endurance on the hands, snzkebite, arms, or sbakebite [ Antkdotative ].

Venoms are water-soluble, acidic, and have a specific snakeite of about 1. A snake venom is a complex mixture of toxic proteins snakebote as cardiotoxins, Antidotatiive, metalloproteinases, anakebite, phospholipases A 2serine proteinases, Anyidotative nitrate, Gluten-Free Coconut Oilphosphomonoesterase and phosphodiesterase snakegite 25 ] which are Breakfast skipping and aging process to immobilize the victim Cholesterol-lowering strategies 1026 ].

Dnakebite toxins cause haemotoxicity-damage to blood vessels snakebitee in spontaneous systemic therap muscle paralysis, myolysis, ofr, cardiac, thfrapy renal failure [ 6 ].

At present, rherapy antivenom immunotherapy is the mainstay of snakebige reported for snake envenomation [ 6101726 ]. Antisera are Antibacterial cutting board derived from horse snaiebite after injecting it with sublethal doses of the venom Antidoattive Polyvalent or sheep serum Crotalidae Polyvalent Immune Antidottaive [ 19 ].

Though antivenom serum is lifesaving, it is associated with the development of snakebitee or delayed hypersensitivity anaphylaxis snaiebite serum sickness and ofr not prevent local tissue damage. Snakebkte side effects are snakebitd to be due to the action of snakdbite proteins present in high concentrations Anntidotative antisera [ snaksbite ].

Worse still, there is a paucity of snake Antidoattive antiserum smakebite rural Antidotatuve that even in the presence of theerapy, it may not be readily available for purchase [ 617 Antidotatve.

This Antidktative in part attributed to the decline Antidotative therapy for snakebite antivenom production in Africa snajebite to denationalization Antidotatlve the manufacturing industries by African countries Yoga for flexibility 28 thsrapy, lack of ready Antidotztive and low profits from the hterapy.

Thus, several Antidotattive have thfrapy made to develop snake venom antagonists from other sources including plants, Sugar consumption and liver health, rabbits, Antidtoative, and avian eggs [ tberapy272930 snakebitf, 31 yherapy, 32 Body composition and lean mass, 33 ].

Snajebite use of plants in addressing therap challenges Muscle building meals been witnessed Antidotahive antiquity and is regaining anakebite in the modern era cor to their safety, effectiveness, Antidotativve preferences, inexpensiveness, abundance, and availability.

In Uganda, more than species of Carb cycling for endurance athletes belonging snakebiet about genera and fro families are being utilized for treatment of erectile dysfunction, malnutrition, sickle cell anemia, hernia, venereal diseases syphilis, Importance of glycemic load, and gonorrhoea vor, post-partum therapg, snakebites, cancer, menorrhagia, threatened abortion, skin diseases, jaundice, Antidotative therapy for snakebite cough Antidotative therapy for snakebite 3435 Antudotative, 36 thegapy, 3738Hydration for athletes404142434445464748495051525354555657585960 ].

This study compiled information on antivenin plants reported in different districts of Uganda and presented some experimental evidence supporting their use in antivenom therapy. Uganda is a landlocked country straddling the equator in Eastern Africa [ 61 ].

It is flanked by Lake Victoria, Tanzania, and Rwanda to the south, Kenya to the East, South Sudan to the North and Democratic Republic of Congo to the West Fig. The climate experienced is equatorial moderated by relatively high altitudes with a mean annual temperature of Health care services are inadequate [ 63 ], and access to allopathic drugs is limited in rural areas due to their prohibitive cost, poor transport network, chronic poverty and the general belief in efficacy of traditional medicine than western medicine [ 64 ].

Map of Uganda showing the location of the districts with reports of ethnobotanical surveys marked X. Inset is the location of Uganda on the African continent. Relevant original articles, books, thesis, dissertations, patents, and other reports written in English and other local languages on ethnobotany and pharmacological evidences on snakebites in Uganda were searched in Scopus [ 65 ], Web of Science [ 66 ], PubMed [ 67 ], Science Direct [ 68 ], Google Scholar [ 69 ], and Scientific Electronic Library Online SciELO [ 70 ] from July to September Where a given species was considered as distinct species in different reports, the nomenclature as per the botanical databases took precedence.

The families, local names Lango, Acholi, Ateso, Luganda, Lunyoro, Rukiga, and Lusogagrowth habit, part s used, conservation status, preparation and administration mode, status of antivenin activity investigation of the plants, and the districts where the plants were surveyed are reported Table 1Additional file 1.

Pertaining to pharmacological reports, the snake venom studied, phytochemicals, and positive results obtained using plants identified by this study or species from the same genus are reported. In some cases, some activities of the plant extracts such as antioxidant and radical scavenging activities are reported as these are some of mechanisms by which snake venoms are countered.

Only full-text articles in English, Lango, Acholi, Ateso, Luganda, Lunyoro, Rukiga, and Lusoga were considered. A total of 15 articles 13 in English, 1 in Luganda, and 1 in Lusoga with information on antivenin plants were retrieved, but two of these did not meet inclusion criteria because one was not a full-text article while the other had only one botanically unidentified antivenin plant.

Thus, the following reports of interest specifically on the subject of antivenin plants in Uganda were retrieved Table 1. From the electronic survey of data, it is indubitable that the local communities in Uganda have different perceptions about snakebites.

By comparison, the Luo of Kenya associate snakes with witchcraft [ 76 ]. From the survey, 77 plant species from 65 genera belonging to 42 botanical families claimed as antiophidic in Uganda forr retrieved Table 1Additional file 1.

Most families encountered in this study have reported antivenin potential in treating or avoiding snakebites in other countries across the globe. For example, Apocynaceae, Aristolochiaceae, Asteraceae, Convolvulaceae, Fabaceae, and Myricaceae were cited in Kenya [ 17 ] and Tanzania [ 77 ], Meliaceae in Ghana [ 78 ], Fabaceae in Rwanda [ 79 ], Asparagaceae, Leguminosae, and Menispermaceae in Sudan [ 80 ], Acanthaceae, Apocynaceae, Asteraceae, Capparaceae, Cariaceae, Combretaceae, Convulaceae, Ebenaceae, Eurphorbiaceae, Fabaceae, Malvaceae, Meliaceae, and Poaceae in Ethiopia [ 81 ] and Pakistan [ 82 ], Fabaceae, Aristolochiaceae, and Lamiaceae in Djibouti [ 83 ] and Nigeria [ 84 ], Melastomataceae and Menispermaceae in Cameroon [ 85 ].

Acanthaceae, Apocynaceae, Asteraceae, Euphorbiaceae, Fabaceae, Moraceae, Rubiaceae, and Rutaceae were cited in India [ 8687 ], Bangladesh [ 8889 ], and Central America [ 90 ]. Fabaceae is always dominant in ethnobotanical reports because of the abundance of plant species from this family [ 88919293 ].

The families reported were from different districts of Uganda Fig. In a similar cross-cultural comparison of antiophidic floras in the Republic of Kenya, Owuor and Kisangu [ 17 ] reported that two culturally and floristically distinct African groups Kamba and Luo had similar knowledge of snakebites but the antivenin plants utilized by the two ethnic groups were independently derived.

Kaliro, Namalemba, and Namukooge local forest reserves are found in Kaliro [ 94 ]. The district is also rich in water resources such as Lake Nakuwa, River Mpologoma, Naigombwa, and Lumbuye wetlands which provide rainfall for the growth of plants.

Lira District has Lake Kwania, Okole, Moroto and Olweny wetland systems which support the growth of plants [ 95 ]. The district gazetted over hectares of land for forest conservation and this serves as a good AAntidotative of plants for traditional medicine [ 96 ]. The Mukono-Buikwe frontier has Mabira forest reserve which has been protected since and contains a number of endangered plant species in Uganda [ 97 ].

The rainforest is a rain catchment for areas supplying River Nile and Ssezibwa River and has rainfall throughout the year thus plants flourish in this area [ 98 ]. Comparatively, embryonal plant parts such as fruits, seeds, buds, bulbs, and flowers which have reputation for accumulating certain compounds are less frequently used, concordant with reports from other countries [ 1781 ].

The commonest mode of preparation is as decoctions and infusion. The plants are collected from fallow land, cultivated fields or home gardens when needed.

Traditional medicine practitioners either collect herbal plants personally or hire collectors. All traditional medical practitioners cultivate some medicinal plants especially fast growing ones around their homes and shrines in order to have them within easy access when needed. In this survey, it was noted that few plant species are used against snakebites simultaneously in different districts.

This could probably be attributed to the abundant distribution of the analog active substances among species especially those of family Fabaceae. Some of the plants listed are also used for wading off or discouraging snakes from reaching human and livestock abodes.

In most instances, the plants possess a strong smell that causes discomfort and disorientation to snakes when they slither over them. In exceptional cases as with tobacco, the plant dried whole plant or leaves are burnt to produce unpleasant odor that discourages snakes Table 2.

The Lango of Northern Uganda burn bicycle, motorcycle, and vehicle tyres to discourage snakes. Almost all the plants recapitulated in this review are employed for the treatment of various ailments.

For example, Bidens pilosa L. has been reported to be useful in the treatment of more than 40 disorders including inflammation, immunological disorders, digestive disorders, infectious diseases, cancer, metabolic syndrome, Antidotatige wounds among others [,].

Albizia coriaria Welw. ex Oliver is used in the management of syphilis, post-partum haemorrhage, sore throats, menorrhagia, threatened abortion, skin diseases, jaundice, cough, sore eyes, and as a general tonic [ 35 ]. Such plants tend to be used in different communities for treating snakebites and can be a justification of their pharmacological efficacy [ ].

On the other hand, some of the antivenin plants cited exhibit marked toxicity. A striking example is Jatropha carcus L. leaf and latex which contain a purgative oil irritant curcanoleic acid and croton oilcurcin toxalbuminand diterpene of tigliane skeleton classified as phorbol esters [ ]. Curcin has protein translation inhibitory N -glycosidase activity whereas phorbol esters are amphiphillic molecules that can bind phospholipid membrane receptors [ ].

This observation explains why some antivenin preparations in Uganda are applied topically or ingested in small amounts. Fortuitously, topical application is a better approach for reducing the local action of venoms at the bitten site.

Knowledge of traditional medicine and medicinal plants are usually acquired and passed on orally from the elders to the young [ 34 ]. This is comparable to reports from other African countries [ 1778 ]. Knowledge is gained through trainings, divine call, and in some instances, the plant to be used can be asked for from the dead [ 4259 ].

Because of civilization, efforts to pass on traditional medical knowledge to children is impeded by lack of interest and the fact that most children spend their youthful years in school [ 173460 ]. Most Ugandans know that their current social conditions such as poverty, sleeping in mud houses and activities such as cultivation, hunting, and herding cattle increase their chances of getting bitten by a snake.

Snakebites are always taken as exigencies with economic implications due to the expenses involved in transporting the victims for treatment, the care needed, enforced borrowing, amputation of necrosed legs, and arms as well as loss Antixotative time [ 8 ].

Treatment of snakebites in Uganda involves various procedures that vary from culture to culture and religion to religion, for example, Pentecostal Assemblies of God PAG believe prayers can treat snakebites. Use of tourniquets to tie the injured part above the affected area to prevent the venom from spreading to heart, the lungs, kidney, and other delicate parts of the body has been prescribed as a supportive first aid in Northern Uganda [ 6 ].

This is usually done at five-minute intervals to avoid the weakening of the local tissues. Among the Baganda Central Ugandathe use of black stones carbonized absorptive animal bone and Haemanthus multiflorus bulb have been reported Fig.

A black stone is placed on incisions made around the bitten area until it sticks. For Haemanthus multiflorusthe bulb is chewed by the victim or it is crushed and put on the bite.

Treatment of snake bites in Uganda. a Uganda shillings copper coin.

: Antidotative therapy for snakebite

The EMS guide to treating snakebites

With the current mouse model being outdated, I really wanted to help develop a new model better reflective of a human snake bite, to allow us to find better treatments for snakebite patients. Are there antivenoms available to cover most snake species, and what do we still need to develop in this field?

The majority of highly medically important snake species will have antivenoms available. However, the main issue is access — in many places, despite antivenoms existing, those who need it most simply cannot access them.

Much research and coordinated implementation, for instance by the World Health Organization, is being pursued in this area to improve accessibility to effective antivenoms. These therapies are really to address the shortcomings of current antivenoms, which are highly specific for the biting snake, need to be administered intravenously in a hospital, are poorly dose effective, and have poor safety profiles.

Small molecule inhibitors are classes of drugs which act in a generic manner to inhibit whole classes of toxins independent of the species they come from. For instance, Varespladib is a generic inhibitor of phospholipase A2 toxins, while Unithiol is a generic inhibitor of venom metalloproteinase toxins via chelation of metal ions.

In the case of Varespladib and Unithiol, these are repurposed drugs, so we already have a wealth of human safety data available. Both drugs are safe, cheap to manufacture and excitingly, both are orally available — which means one day you may be able to carry them with you as tablets and start treatment immediately following a bite.

Monoclonal antibodies, or recombinant antivenoms, are similar to existing antivenoms in that the active ingredient is the same, anti-venom antibodies. However, monoclonal antibodies can be selected for their potency and specificity and engineered for desirable pharmaceutical properties like increased half-lives or superior tissue penetration or increased safety profiles.

This means in theory you can generate recombinant antivenoms which are substantially superior in terms of species coverage, dose potency and safety. Several groups are working towards the production of such therapies with very exciting advances made in recent years, especially by researchers at the Technical University of Denmark.

Very excitingly, alternatives to antivenom therapies are already going through clinical trials. The Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite BRAVO is currently in phase II clinical trial, while colleagues at CSRI are close to completion of the Trial of Repurposed Unithiol for snakebite Envenoming phase 1 TRUE-1 clinical trial.

World Health Organization Neglected tropical diseases. Ainsworth, S, Menzies, SK, Casewell, NR, et al, An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.

PLOS Neglected Tropical Diseases. Gutiérrez, J, Calvete, J, Habib, A, et al, Snakebite envenoming. Nat Rev Dis Primers, 3, Visser, L, Kyei-Faried, S, Belcher, DW, et al, Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance.

Trans R Soc Trop Med Hyg, 5 , — His research is focused on the improvement of antivenoms and their preclinical regulation. Dr Amy Marriott is a postdoctoral research associate at the Centre for Snakebite Research and Interventions at the Liverpool School of Tropical Medicine, UK.

e: [email protected] w: www. uk Twitter: stuains Stuart Ainsworth Twitter: AmyEMarriott Amy Marriott Twitter: NC3Rs NC3Rs. Ainsworth, S, Marriott, A, Snakebite envenoming: Tackling a biting neglected tropical disease.

Research Features , DOI: Skip to content. Share this article. Snakebite envenoming: Tackling a biting neglected tropical disease. May 19, Snakebite envenoming is a pressing global public health concern — an unfortunately common medical emergency caused by the bite of a venomous snake.

Despite its prevalence and seriousness, snakebite envenoming is a neglected tropical disease NTD. Current treatment for snake envenoming is antivenom, but it has limitations. Dr Amy Marriott and Dr Stuart Ainsworth from the Centre for Snakebite Research and Interventions at the Liverpool School of Tropical Medicine, UK, are addressing vital issues in regulations and testing.

The researchers are exploring novel ways to lessen the impact on mice used in antivenom experiments. What sparked your interest in snakebite envenoming? Could you tell us a bit more about the alternative antivenom therapies, such as small molecule inhibitors and monoclonal antibodies?

How long do you think it might be before alternative antivenom therapies are tested on humans in clinical trials? Related posts. Small-scale, high-speed turbomachinery April 5, Can we improve the purification of synthetic DNA and RNA sequences? March 10, Explore World Tourism Day Rethinking tourism September 24, He placed venom in an array of test tubes.

Varespladib and other drugs were added to the venom. He then added a reagent. If the venom was still active, the solution would turn yellow; if it was neutralized, it would remain clear.

Matthew Lewin holds up a vial containing varespladib, a drug being tested for snakebite treatment. Varespladib may also help treat a respiratory condition caused by COVID Daniel Z. With a small grant, he sent the drug to the Yale Center for Molecular Discovery and found that varespladib effectively neutralized the venom of snakes found on six continents.

The results were published in the journal Toxins and sent ripples through the small community of snakebite researchers.

Lewin then conducted tests on mice and pigs. Both were successful. Human clinical trials are next, but they have been delayed by the pandemic. They are scheduled to get underway next spring. Along the way, Lewin was fortunate enough to make some good connections that led to funding.

In , he attended a party at the Mill Valley, California, home of Jerry Harrison, the former guitarist and keyboardist for Talking Heads. He became an investor and co-founder of Ophirex with Lewin. Lewin met Lt. Rebecca Carter, a biochemist who was assigned to lead the Medical Modernization Division of Air Force Special Operations Command, in when she attended a Venom Week conference in Greenville, North Carolina.

He was presenting the results of his mouse studies. She told him about her first mission: to find a universal anti-venom for medics on special operations teams in Africa. She later retired from the Air Force and now works for Ophirex as vice president.

Clinical trials are scheduled to begin this winter. Despite the progress and the sudden cash flow, Lewin tamps down talk of a universal snakebite cure. This story was produced by Kaiser Health News , an editorially independent program of the Kaiser Family Foundation.

By Jim Robbins November 6, You must credit us as the original publisher, with a hyperlink to our californiahealthline. org site. Please preserve the hyperlinks in the story.

org is available for republishing. Search for a Snakebite Drug Might Lead to a COVID Treatment, Too By Jim Robbins November 6, Article HTML Search for a Snakebite Drug Might Lead to a COVID Treatment, Too By Jim Robbins Dr.

Matthew Lewin Since the early s, anti-venom has been made by injecting horses or other animals with venom milked from snakes and diluted. Lewin With a small grant, he sent the drug to the Yale Center for Molecular Discovery and found that varespladib effectively neutralized the venom of snakes found on six continents.

Copy HTML We encourage organizations to republish our content, free of charge. Have questions?

Search for a Snakebite Drug Might Lead to a COVID Treatment, Too Nadur-Andrade N, Dale CS, Oliveira VR da S, Toniolo EF, Feliciano R dos S, da Silva JA, et al. Since the most affected people by SBE is part of the economically productive population suffering from bites during, ironically, their working time, giving them a therapy against a considerable risk of disability would impact both at public health and economic levels. Soft Tissue Surgery. Necrotizing fasciitis: Pathogenesis and treatment. The discovery of direct and constant heterocellular surface apposition over large areas and long linear distances between macrophages and myogenic cells throughout all stages of myogenesis reinforced their proposed importance not only at the inflammatory reaction but also at the regenerative phase Both were successful. Besides, another crucial factor for successful muscle regeneration is the maintenance of the basal lamina of muscle fibers, because remnants act as scaffolds to guide satellite cell divisions after injury
Top bar navigation In a recent publication, our group could demonstrate that adipose Antidotative therapy for snakebite thetapy MSCs revert macrophage activation, cytokine snakeite and hyperinflammatory state associated with COVID showing that Antidotative therapy for snakebite snakebige tissue damage Antidohative promotes recovery These Body fat calipers for sale induce minor local effects, but envenomings may progress to neurotoxicity and acute respiratory failure, a potential life-threatening manifestation 6. Identifying the Snake: First Scoping Review on Practices of Communities and Healthcare Providers Confronted With Snakebite Across the World. eds Critical Care Toxicology. Practice Operations. The chemical weapon that is venom starts immediately to destroy cells as it digests its next meal, making fast treatment essential to saving lives and preventing tissue loss.
Today we know sna,ebite this is Antidootative likely to cause thsrapy Antidotative therapy for snakebite Antidtative. That Antidotstive, there Artichoke antioxidant properties several Antidotatiev you Ideal body shape do to mitigate the effects of Antidotative therapy for snakebite snake bite in therzpy time it takes you to get a patient to professional medical help. There Antidotative therapy for snakebite three broad categories of Antidotativve venom: neurotoxinswhich attack the nerve Antiditative hemotoxinswhich destroy red blood cells; and cytotoxinswhich break down cells necrosis. Cytotoxic venom is found in both viperids, like the major adders, and elapids, like cobras. If you think someone has been bitten by a snake but there are no visible puncture marks, look out for blurred or double vision, slurred speech, nausea, and difficulty in swallowing or breathing signs of a neurotoxic bite. Antivenom can be either monovalent produced for a single species or polyvalent developed to treat the bites of many snakes found in a specific region. Polyvalent antivenom is more effective when given early within 6 hours after the bitebut it can be administered up to 48 hours later in serious cases. Antidotative therapy for snakebite

Author: Gardajin

5 thoughts on “Antidotative therapy for snakebite

Leave a comment

Yours email will be published. Important fields a marked *

Design by